BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-13.27%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$676M
AUM Growth
+$676M
(-20%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
90.65%
Holding
26
New
–
Increased
2
Reduced
2
Closed
2
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$14.3M |
| 2 |
Savara
SVRA
|
$8.41M |
Top Sells
| 1 |
Olema Pharmaceuticals
OLMA
|
$2.35M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$1.44M |
| 3 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$632K |
| 4 |
Nautilus Biotechnolgy
NAUT
|
$591K |
Sector Composition
| 1 | Healthcare | 99.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$2.71B
| $219M | 32.46% | 10,719,110 | – | – |
|
2
Nuvalent
NUVL
$5.52B
| $103M | 15.19% | 1,447,267 | – | – |
|
3
Pharvaris
PHVS
$1.39B
| $51.9M | 7.67% | 3,303,381 | – | – |
|
4
Disc Medicine
IRON
$2.07B
| $48.8M | 7.22% | 983,500 | – | – |
|
5
Dianthus Therapeutics
DNTH
$759M
| $48.8M | 7.22% | 2,689,707 | – | – |
|
|
6
Savara
SVRA
$567M
| $48.8M | 7.21% | 17,600,621 +3,035,164 | +21% | +$8.41M |
|
|
7
Solid Biosciences
SLDB
$427M
| $29.3M | 4.33% | 7,911,669 +3,877,087 | +96% | +$14.3M |
|
|
8
Olema Pharmaceuticals
OLMA
$375M
| $25.7M | 3.81% | 6,843,954 -626,260 | -8% | -$2.35M |
|
9
Rapid Micro Biosystems
RPID
$107M
| $22.3M | 3.29% | 8,434,560 | – | – |
|
10
Cidara Therapeutics
CDTX
$1.66B
| $15.1M | 2.24% | 703,080 | – | – |
|
|
UPB
11
Upstream Bio, Inc. Common Stock
UPB
$923M
| $14M | 2.08% | 2,295,322 | – | – |
|
12
Annexon
ANNX
$226M
| $10.1M | 1.5% | 5,249,069 | – | – |
|
13
Atea Pharmaceuticals
AVIR
$267M
| $7.43M | 1.1% | 2,485,638 | – | – |
|
14
Kyverna Therapeutics
KYTX
$160M
| $6.5M | 0.96% | 3,368,370 | – | – |
|
15
X4 Pharmaceuticals
XFOR
$84.2M
| $4M | 0.59% | 16,915,784 | – | – |
|
16
Cabaletta Bio
CABA
$133M
| $3.82M | 0.57% | 2,760,888 | – | – |
|
17
Tango Therapeutics
TNGX
$747M
| $3.72M | 0.55% | 2,712,008 | – | – |
|
18
Xilio Therapeutics
XLO
$36.3M
| $3.31M | 0.49% | 4,566,817 | – | – |
|
19
Mersana Therapeutics
MRSN
$36.5M
| $2.98M | 0.44% | 8,663,673 | – | – |
|
20
Century Therapeutics
IPSC
$42.5M
| $2.58M | 0.38% | 5,410,361 | – | – |
|
21
C4 Therapeutics
CCCC
$185M
| $1.78M | 0.26% | 1,111,910 | – | – |
|
22
Invivyd
IVVD
$204M
| $1.09M | 0.16% | 1,799,595 | – | – |
|
|
23
Nautilus Biotechnolgy
NAUT
$85.9M
| $923K | 0.14% | 1,072,421 -686,579 | -39% | -$591K |
|
|
24
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $899K | 0.13% | 100,000 | – | – |
|
|
SYRS
25
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – | -2,750,151 | Closed | -$632K |
|